Tellgen Announces Strategic Investment in CytoCares to Advance Autoimmune Disease Diagnosis and Therapy
Tellgen Corporation announced its exclusive strategic investment in CytoCares (Shanghai) Inc., marking an important milestone in building an integrated “Diagnosis + Therapy” ecosystem in the field of autoimmune diseases. This collaboration aligns with Tellgen’s long-term strategy to extend its diagnostic expertise into therapeutic innovation and strengthen its capability to provide full-cycle healthcare solutions. Mr. Yao …